Status:
COMPLETED
Study to Evaluate the Effect of a Probiotic in COVID-19
Lead Sponsor:
Bioithas SL
Conditions:
COVID-19
Coronavirus Infection
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
A prospective case-control pilot study to evaluate the possible effect of a probiotic mixture in the improvement of symptoms, the reduction in the number of days of hospitalization and the increase in...
Detailed Description
In this study, the investigators hypothesize a positive effect of probiotic on the gut microbiome that could led to produce a less severe clinical evolution of the disease.
Eligibility Criteria
Inclusion
- Patients with a confirmed diagnosis of SARS-Cov.2 infection using the PCR and that require admission to the hospitalization area.
Exclusion
- Inability or refusal to sign informed consent.
- Allergy or intolerance to the intervention product or its components.
Key Trial Info
Start Date :
May 4 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2021
Estimated Enrollment :
41 Patients enrolled
Trial Details
Trial ID
NCT04390477
Start Date
May 4 2020
End Date
April 30 2021
Last Update
April 29 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitario del Vinalopó
Elche, Alicante, Spain, 03293
2
Hospital Universitario de Torrevieja
Torrevieja, Alicante, Spain, 03198